Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. (Q43451461)
Jump to navigation
Jump to search
scientific article published in May 2013
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. |
scientific article published in May 2013 |
Statements
1 reference
Durable efficacy and safety of raltegravir versus efavirenz when combined with tenofovir/emtricitabine in treatment-naive HIV-1-infected patients: final 5-year results from STARTMRK. (English)
1 reference
Jürgen K Rockstroh
1 reference
Yazdan Yazdanpanah
1 reference
Michael S Saag
1 reference
Bach-Yen Nguyen
1 reference
STARTMRK Investigators
1 reference
Hedy Teppler
1 reference
Jeffrey L Lennox
1 reference
Edwin DeJesus
1 reference
Hong Wan
1 reference
Anthony J Rodgers
1 reference
Monica L Walker
1 reference
Michael Miller
1 reference
Mark J DiNubile
1 reference
Randi Leavitt
1 reference
Peter Sklar
1 reference
1 May 2013
1 reference
1 reference
Identifiers
1 reference